- Home
- RLGT vs ACHV Comparison
RLGT vs ACHV Comparison
Compare RLGT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLGT | ACHV |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.6M | 239.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RLGT | ACHV |
|---|---|---|
| Price | $6.60 | $4.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $8.00 | ★ $15.50 |
| AVG Volume (30 Days) | 172.7K | ★ 598.8K |
| Earning Date | 02-09-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.35 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $925,786,000.00 | N/A |
| Revenue This Year | $3.77 | N/A |
| Revenue Next Year | $3.51 | N/A |
| P/E Ratio | $20.87 | ★ N/A |
| Revenue Growth | ★ 16.42 | N/A |
| 52 Week Low | $5.44 | $1.84 |
| 52 Week High | $7.94 | $5.78 |
Technical Indicators
Market Signals| Indicator | RLGT | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 44.93 |
| Support Level | $6.62 | $4.23 |
| Resistance Level | $6.84 | $4.86 |
| Average True Range (ATR) | 0.17 | 0.26 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 51.82 | 8.85 |
Price Performance
Historical ComparisonAbout RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.